PolarityTE (NASDAQ: PTE)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.000 | -2.500 | -0.5000 | ||||
REV | 730.000K | 741.000K | 11.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of PolarityTE (NASDAQ: PTE) through any online brokerage.
Other companies in PolarityTE’s space includes: Benitec Biopharma (NASDAQ:BNTC), Addex Therapeutics (NASDAQ:ADXN), Histogen (NASDAQ:HSTO), Hillstream BioPharma (NASDAQ:HILS) and Bellicum Pharmaceuticals (NASDAQ:BLCM).
The latest price target for PolarityTE (NASDAQ: PTE) was reported by Cantor Fitzgerald on Tuesday, May 12, 2020. The analyst firm set a price target for 3.00 expecting PTE to rise to within 12 months (a possible 79.64% upside). 0 analyst firms have reported ratings in the last year.
The stock price for PolarityTE (NASDAQ: PTE) is $1.67 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for PolarityTE.
PolarityTE’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for PolarityTE.
PolarityTE is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.